High symptom burden after oesophagectomy
On postoperative day 3, about one in five patients had high symptom burden, and the symptoms most linked to others differed between patient groups.
Newsletter
Every new paper in this field, in your inbox.
On postoperative day 3, about one in five patients had high symptom burden, and the symptoms most linked to others differed between patient groups.
An enhanced-recovery pathway after endoscopic removal of small upper gastrointestinal lesions shortened hospital stays without increasing complications.
In nine comparative studies of minimally invasive esophagectomy for esophageal cancer, uniportal VATS was associated with less pneumonia and a shorter stay than multiportal VATS—but the evidence is not strong enough to establish a preferred approach.
A tubeless recovery strategy after laparoscopy-assisted gastrectomy was associated with a shorter hospital stay and better early quality of life in selected non-high-risk patients.
After neoadjuvant therapy for esophageal cancer, robotic surgery more often included left recurrent laryngeal nerve (RLN) node dissection and retrieved more nodes there—but was associated with more overall complications.
In a meta-analysis of 7,518 patients, ICG-guided lymphadenectomy was associated with better 3- and 5-year survival and greater node yield—but the evidence does not establish causation.
In this two-centre cohort, prophylactic balloon dilation was associated with less early delayed conduit emptying and pneumonia after esophagectomy.
In patients with gastric cancer and positive peritoneal lavage cytology or localized peritoneal metastasis, upfront chemotherapy followed by surgery yields better outcomes than surgery followed by chemotherapy.
More than one-third of patients with esophageal cancer experience significant financial toxicity after esophagectomy, which can complicate recovery and quality of life.
Robotic-assisted minimally invasive esophagectomy (RAMIE) offers better functional outcomes, reduced morbidity, and improved quality of life compared to traditional open surgery for esophageal cancer without compromising oncological results.